Guadalupe Martínez-Chacón

Guadalupe Martínez-Chacón

Auto-generated profile, based on publicly available information

Guadalupe Martínez-Chacón

Departamento de Bioquímica Y Biología Molecular Y Genética, Facultad de Enfermería Y Terapia Ocupacional, Universidad de Extremadura, Cáceres, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MRM Rodríguez-Arribas
M Rodríguez-Arribas
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
José Manuel Bravo San PedroJosé Manuel Bravo San Pedro
José Manuel Bravo San Pedro
Patricia Gomez-SuagaPatricia Gomez-Suaga
Patricia Gomez-Suaga
RGRubén Gómez-Sánchez
Rubén Gómez-Sánchez
MNMireia Niso-Santano
Mireia Niso-Santano

1 January 2020 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
FVFrancisco Javier Vela
Francisco Javier Vela
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
ABAlberto Ballestin
Alberto Ballestin
Jose Luis Campos SánchezJose Luis Campos Sánchez
Jose Luis Campos Sánchez
Francisco Miguel Sánchez MargalloFrancisco Miguel Sánchez Margallo
Francisco Miguel Sánchez Margallo
EAElena Abellán
Elena Abellán
Objective: Peripheral nerve repair is required after traumatic injury. This common condition represents a major public health problem worldwide. Recovery after nerve repair depends on several factors, including the severity of the injury, the nerve involved, and the surgeon’s technical skills. Despite the precise microsurgical repair of nerve lesions, adequate functional recovery is not always achieved and, therefore, the regeneration process and surgical techniques are still being studied. Pre-clinical animal models are essential for this research and, for this reason, the focus of the present systematic review (according to the PRISMA statement) was to analyze the different animal models used in pre-clinical peripheral nerve repair studies. Data sources: Original articles, published in English from 2000 to 2018, were collected using the Web of Science, Scopus, and PubMed databases. Data selection: Only preclinical trials on direct nerve repair were included in this review. The articles were evaluated by the first two authors, in accordance with predefined data fields. Outcome measures: The primary outcomes included functional motor abilities, daily activity and regeneration rate. Secondary outcomes included coaptation technique and animal model. Results: This review yielded 267 articles, of which, after completion of the screening, 49 studies were analyzed. There were 1425 animals in those 49 studies, being rats, mice, guinea pigs, rabbits, cats and dogs the different pre-clinical models. The nerves used were classified into three groups: head and neck (11), forelimb (8) and hindlimb (30). The techniques used to perform the coaptation were: microsuture (46), glue (12), laser (8) and mechanical (2). The follow-up examinations were histology (43), electrophysiological analysis (24) and behavioral observation (22). Conclusion: The most widely used animal model in the study of peripheral nerve repair is the rat. Other animal models are also used but the cost-benefit of the rat model provides several strengths over the others. Suture techniques are currently the first option for nerve repair, but the use of glues, lasers and bioengineering materials is increasing. Hence, further research in this field is required to improve clinical practice.

21 July 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
MNMireia Niso-Santano
Mireia Niso-Santano
MRMario Rodríguez-Arribas
Mario Rodríguez-Arribas
RGRubén Gómez-Sánchez
Rubén Gómez-Sánchez
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
Jose Manuel FuentesJose Manuel Fuentes
Jose Manuel Fuentes

1 June 2016 in Data in Brief
Verified
Journal Article
Open access
RGRubén Gómez-Sánchez
Rubén Gómez-Sánchez
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
MRMario Rodríguez-Arribas
Mario Rodríguez-Arribas
José Manuel Bravo San PedroJosé Manuel Bravo San Pedro
José Manuel Bravo San Pedro
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
Rosa A. Gonzalez-PoloRosa A. Gonzalez-Polo
Rosa A. Gonzalez-Polo
We characterized the dynamics of autophagy in vitro using four different cell systems and analyzing markers widely used in this field, i.e. LC3 (microtubule-associated protein 1 light chain 3; protein recruited from the cytosol (LC3-I) to the autophagosomal membrane where it is lipidated (LC3-II)) and p62/SQSTM1 (adaptor protein that serves as a link between LC3 and ubiquitinated substrates), (Klionsky et al., 2016) [1]. Data provided include analyses of protein levels of LC3 and p62 by Western-blotting and endogenous immunofluorescence experiments, but also p62 mRNA levels obtained by quantitative PCR (qPCR). To monitor the turnover of these autophagy markers and, thus, measure the flux of this pathway, cells were under starvation conditions and/or treated with bafilomycin A1 (Baf. A1) to block fusion of autophagosomes with lysosomes.

27 August 2021 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
MPMarta Paredes
Marta Paredes
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
EUElisabet Uribe-Carretero
Elisabet Uribe-Carretero
ABAriadna Bargiela
Ariadna Bargiela
MNMireia Niso-Santano
Mireia Niso-Santano
Autophagy is a conserved intracellular catabolic pathway that removes cytoplasmic components to contribute to neuronal homeostasis. Accumulating evidence has increasingly shown that the induction of autophagy improves neuronal health and extends longevity in several animal models. Therefore, there is a great interest in the identification of effective autophagy enhancers with potential nutraceutical or pharmaceutical properties to ameliorate age-related diseases, such as neurodegenerative disorders, and/or promote longevity. Queen bee acid (QBA, 10-hydroxy-2-decenoic acid) is the major fatty acid component of, and is found exclusively in, royal jelly, which has beneficial properties for human health. It is reported that QBA has antitumor, anti-inflammatory, and antibacterial activities and promotes neurogenesis and neuronal health; however, the mechanism by which QBA exerts these effects has not been fully elucidated. The present study investigated the role of the autophagic process in the protective effect of QBA. We found that QBA is a novel autophagy inducer that triggers autophagy in various neuronal cell lines and mouse and fly models. The beclin-1 (BECN1) and mTOR pathways participate in the regulation of QBA-induced autophagy. Moreover, our results showed that QBA stimulates sirtuin 1 (SIRT1), which promotes autophagy by the deacetylation of critical ATG proteins. Finally, QBA-mediated autophagy promotes neuroprotection in Parkinson’s disease in vitro and in a mouse model and extends the lifespan of Drosophila melanogaster. This study provides detailed evidences showing that autophagy induction plays a critical role in the beneficial health effects of QBA.

15 June 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
ECEva Alegre Cortés
Eva Alegre Cortés
AMAlicia Muriel-González
Alicia Muriel-González
SCSaray Canales-Cortés
Saray Canales-Cortés
EUElisabet Uribe-Carretero
Elisabet Uribe-Carretero
GMGuadalupe Martínez-Chacón
Guadalupe Martínez-Chacón
SYSOKHNA M. S. YAKHINE-DIOP
SOKHNA M. S. YAKHINE-DIOP
Parkinson’s disease (PD) is a neurodegenerative disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. This neuronal loss, inherent to age, is related to exposure to environmental toxins and/or a genetic predisposition. PD-induced cell death has been studied thoroughly, but its characterization remains elusive. To date, several types of cell death, including apoptosis, autophagy-induced cell death, and necrosis, have been implicated in PD progression. In this study, we evaluated necroptosis, which is a programmed type of necrosis, in primary fibroblasts from PD patients with and without the G2019S leucine-rich repeat kinase 2 (LRRK2) mutation and in rotenone-treated cells (SH-SY5Y and fibroblasts). The results showed that programmed necrosis was not activated in the cells of PD patients, but it was activated in cells exposed to rotenone. Necrostatin-1 (Nec-1), an inhibitor of the necroptosis pathway, prevented rotenone-induced necroptosis in PD models. However, Nec-1 affected mitochondrial morphology and failed to protect mitochondria against rotenone toxicity. Therefore, despite the inhibition of rotenone-mediated necroptosis, PD models were susceptible to the effects of both Nec-1 and rotenone.